dapsone has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 31 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " We describe the clinical, serologic and immunogenetic data in a patient with manifestations of Sjögren's syndrome who developed urticarial vasculitis and photosensitive annular SCLE which were effectively treated with oral dapsone." | 7.68 | Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. ( Callen, JP; Holtman, JH; Klein, J; Neustadt, DH, 1990) |
| " We describe the clinical, serologic and immunogenetic data in a patient with manifestations of Sjögren's syndrome who developed urticarial vasculitis and photosensitive annular SCLE which were effectively treated with oral dapsone." | 3.68 | Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. ( Callen, JP; Holtman, JH; Klein, J; Neustadt, DH, 1990) |
| "Dapsone was discontinued in 9 patients: in 4 due to reversible side effects and in 5 patients due to poor efficacy." | 2.53 | Dapsone as Second-Line Treatment for Cutaneous Lupus Erythematosus? A Retrospective Analysis of 34 Patients and a Review of the Literature. ( Aberer, E; Klebes, M; Wutte, N, 2016) |
| "The mainstays of treatment of cutaneous lupus erythematosus (LE) are topical and intralesional steroids, sunscreen, and the antimalarials." | 2.38 | Treatment of cutaneous lupus erythematosus. ( Kerdel, FA; Rothe, MJ, 1992) |
| "A treatment with dapsone was prescribed and yielded rapid improvement." | 1.56 | Scarring alopecia in chronic cutaneous lupus erythematosus with neutrophils: A new scenario with therapeutic connotations. ( Bello, JA; Cabo, F; Fernandez-Flores, A; Hermosa-Gelbard, A; Pérez, A, 2020) |
| "Vesico-bullous subacute cutaneous lupus erythematosus is an uncommon and severe presentation." | 1.38 | Vesico-bullous subacute cutaneous lupus erythematosus--an uncommon entity successfully treated with dapsone and hydroxychloroquine. ( Alves, R; Pinto-Almeida, T; Sanches, M; Selores, M, 2012) |
| "Bullous systemic lupus erythematosus (BSLE) is a rare subset of systemic lupus erythematosus that is often associated with autoimmunity to type VII collagen." | 1.33 | Bullous Systemic Lupus Erythematosus as an Initial Manifestation of SLE. ( Fujimoto, W; Hamada, T; Iwatsuki, K; Matsuura, H; Yamada, J, 2005) |
| "We describe a patient with systemic lupus erythematosus (SLE) who exhibited severe cutaneous involvement characterized by the simultaneous presence of acute, subacute and discoid lesions in association with anti-S1 antibodies." | 1.30 | A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with Dapsone. ( Bernacchi, E; Bombardieri, S; Mosca, M; Neri, R, 1999) |
| "Treatment with prednisolone (15 mg/day), chloroquine phosphate (200 mg/ day), cyclosporine (5 mg/kg daily), and gold (10 mg/day) failed to reduce pruritic plaque formation, and pulse methylprednisolone therapy led to only a transient remission." | 1.29 | Widespread pruritic plaques in a patient with subacute cutaneous lupus erythematosus and hypocomplementemia: response to dapsone therapy. ( Hatta, N; Imai, T; Sakai, H; Takata, M; Takehara, K; Tsutsui, K, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.23) | 18.7374 |
| 1990's | 11 (35.48) | 18.2507 |
| 2000's | 6 (19.35) | 29.6817 |
| 2010's | 11 (35.48) | 24.3611 |
| 2020's | 2 (6.45) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, H | 1 |
| Gudjonsson, JE | 1 |
| Kahlenberg, JM | 2 |
| Fernandez-Flores, A | 1 |
| Hermosa-Gelbard, A | 1 |
| Pérez, A | 1 |
| Bello, JA | 1 |
| Cabo, F | 1 |
| Nutan, F | 1 |
| Ortega-Loayza, AG | 1 |
| Hsieh, FN | 1 |
| Yu-Yun Lee, J | 1 |
| Zampeli, E | 1 |
| Moutsopoulos, HM | 1 |
| Klebes, M | 1 |
| Wutte, N | 1 |
| Aberer, E | 2 |
| Stannard, JN | 1 |
| Juhász, M | 1 |
| Rogge, M | 1 |
| Chen, M | 1 |
| Czernik, A | 1 |
| Jung Kim, S | 1 |
| Geller, L | 1 |
| Kuhn, A | 2 |
| Bata-Csörgő, Z | 1 |
| Caproni, M | 1 |
| Dreher, A | 1 |
| Frances, C | 2 |
| Gläser, R | 1 |
| Klötgen, HW | 1 |
| Landmann, A | 1 |
| Marinovic, B | 1 |
| Nyberg, F | 1 |
| Olteanu, R | 1 |
| Ranki, A | 1 |
| Szepietowski, JC | 1 |
| Volc-Platzer, B | 1 |
| Abe, M | 1 |
| Shimizu, A | 1 |
| Yokoyama, Y | 1 |
| Takeuchi, Y | 1 |
| Ishikawa, O | 1 |
| Renner, R | 1 |
| Sticherling, M | 1 |
| Ruland, V | 1 |
| Bonsmann, G | 1 |
| Chang, AY | 1 |
| Werth, VP | 1 |
| Al-Mutairi, N | 1 |
| Pinto-Almeida, T | 1 |
| Sanches, M | 1 |
| Alves, R | 1 |
| Selores, M | 1 |
| Barete, S | 1 |
| Ayoub, N | 1 |
| Piette, JC | 1 |
| Wenzel, J | 1 |
| Bieber, T | 1 |
| Uerlich, M | 1 |
| Tüting, T | 1 |
| Fujimoto, W | 1 |
| Hamada, T | 1 |
| Yamada, J | 1 |
| Matsuura, H | 1 |
| Iwatsuki, K | 1 |
| Callen, JP | 2 |
| Tsutsui, K | 1 |
| Imai, T | 1 |
| Hatta, N | 1 |
| Sakai, H | 1 |
| Takata, M | 1 |
| Takehara, K | 1 |
| Mok, CC | 2 |
| Lau, CS | 2 |
| Shuster, J | 1 |
| Wong, RW | 1 |
| Neri, R | 1 |
| Mosca, M | 1 |
| Bernacchi, E | 1 |
| Bombardieri, S | 1 |
| Christiansen, J | 1 |
| Tegner, E | 1 |
| Irestedt, M | 1 |
| Davies, MG | 1 |
| Newman, P | 1 |
| Rothe, MJ | 1 |
| Kerdel, FA | 1 |
| Pascual Velasco, F | 1 |
| Joubert, B | 1 |
| Devant, O | 1 |
| Amblard, P | 1 |
| Holtman, JH | 1 |
| Neustadt, DH | 1 |
| Klein, J | 1 |
| Rock, B | 1 |
| Patel, HP | 1 |
11 reviews available for dapsone and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
Treatment of cutaneous lupus erythematosus: current approaches and future strategies.
Topics: Antibodies, Monoclonal; Dapsone; Humans; Hydroxychloroquine; Interferon Type I; Lupus Erythematosus, | 2020 |
Cutaneous Lupus: A Brief Review of Old and New Medical Therapeutic Options.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antimalarials; Calcineurin Inhibitors; Dapsone; Hum | 2017 |
Leukocytoclastic Vasculitis Concurrent With Bullous Systemic Lupus Erythematosus Manifesting Striking Wood-Grain and Wi-Fi Sign-like Purpuric Lesions.
Topics: Biopsy, Needle; Dapsone; Humans; Immunohistochemistry; Lupus Erythematosus, Cutaneous; Male; Middle | 2019 |
Dapsone as Second-Line Treatment for Cutaneous Lupus Erythematosus? A Retrospective Analysis of 34 Patients and a Review of the Literature.
Topics: Adult; Aged; Aged, 80 and over; Antimalarials; Dapsone; Female; Humans; Lupus Erythematosus, Cutaneo | 2016 |
Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, | 2016 |
The different faces of cutaneous lupus erythematosus.
Topics: Antimalarials; Azathioprine; Biomarkers; Dapsone; Dermatologic Agents; Diagnosis, Differential; Drug | 2009 |
Cutaneous lupus erythematosus: update of therapeutic options part II.
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murin | 2011 |
Treatment of cutaneous lupus.
Topics: Administration, Topical; Antimalarials; Calcineurin Inhibitors; Dapsone; Glucocorticoids; Humans; Im | 2011 |
[Systemic treatment of cutaneous lupus erythematosus].
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antimal | 2003 |
Treatment of cutaneous lesions in patients with lupus erythematosus.
Topics: Adrenal Cortex Hormones; Antimalarials; Azathioprine; Combined Modality Therapy; Dapsone; Drug Thera | 1994 |
Treatment of cutaneous lupus erythematosus.
Topics: Adrenal Cortex Hormones; Antimalarials; Dapsone; Drug Resistance; Humans; Immunosuppressive Agents; | 1992 |
20 other studies available for dapsone and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
Scarring alopecia in chronic cutaneous lupus erythematosus with neutrophils: A new scenario with therapeutic connotations.
Topics: Alopecia; Antimalarials; Autoimmune Diseases; Biopsy; Chronic Disease; Cicatrix; Dapsone; Diagnosis, | 2020 |
Dapsone: an old drug effective for subacute cutaneous lupus erythematosus.
Topics: Anti-Infective Agents; Dapsone; Female; Humans; Lupus Erythematosus, Cutaneous; Middle Aged | 2019 |
Case of Pediatric Bullous Systemic Lupus Erythematosus Treated with Intravenous Immunoglobulin.
Topics: Adolescent; Dapsone; Female; Humans; Immunoglobulins, Intravenous; Lupus Erythematosus, Cutaneous; S | 2017 |
S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).
Topics: Adrenal Cortex Hormones; Antimalarials; Biological Products; Calcineurin Inhibitors; Consensus; Daps | 2017 |
A possible inhibitory action of diaminodiphenyl sulfone on tumour necrosis factor-alpha production from activated mononuclear cells on cutaneous lupus erythematosus.
Topics: Adult; Anti-Inflammatory Agents; Cells, Cultured; Dapsone; Depression, Chemical; Humans; Immunohisto | 2008 |
Nosology and therapeutic options for lupus miliaris disseminatus faciei.
Topics: Adult; Dapsone; Drug Therapy, Combination; Facial Dermatoses; Female; Humans; Lupus Erythematosus, C | 2011 |
Vesico-bullous subacute cutaneous lupus erythematosus--an uncommon entity successfully treated with dapsone and hydroxychloroquine.
Topics: Antirheumatic Agents; Blister; Dapsone; Folic Acid Antagonists; Humans; Hydroxychloroquine; Lupus Er | 2012 |
[Classification of dermatologic manifestations in lupus erythematosus].
Topics: Acitretin; Adrenal Cortex Hormones; Adult; Antimalarials; Clinical Trials as Topic; Dapsone; Dermato | 2003 |
Bullous Systemic Lupus Erythematosus as an Initial Manifestation of SLE.
Topics: Betamethasone; Biopsy, Needle; Dapsone; Dermatologic Agents; Diagnosis, Differential; Drug Therapy, | 2005 |
Widespread pruritic plaques in a patient with subacute cutaneous lupus erythematosus and hypocomplementemia: response to dapsone therapy.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Complement C3 | 1996 |
Dapsone syndrome in cutaneous lupus erythematosus.
Topics: Adult; Dapsone; Fatal Outcome; Female; Humans; Leprostatic Agents; Lupus Erythematosus, Cutaneous; M | 1996 |
Dapsone and liver failure.
Topics: Adult; Chemical and Drug Induced Liver Injury; Dapsone; Drug Monitoring; Humans; Liver Failure; Lupu | 1998 |
Toxicities of dapsone in the treatment of cutaneous manifestations of rheumatic diseases.
Topics: Adolescent; Adult; Anti-Infective Agents; Dapsone; Drug Hypersensitivity; Female; Humans; Lupus Eryt | 1998 |
A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with Dapsone.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dapsone; Female; Hum | 1999 |
Dapsone hypersensitivity syndrome in a patient with cutaneous lupus erythematosus.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Drug Hypersensitivity; Female; Follow-Up Stu | 1999 |
Linear cutaneous lupus erythematosus in association with ipsilateral submandibular myoepithelial sialadenitis.
Topics: Administration, Oral; Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Dapsone; Female; | 2001 |
[Dapsone syndrome].
Topics: Adult; Dapsone; Drug Hypersensitivity; Female; Humans; Lupus Erythematosus, Cutaneous; Syndrome | 1991 |
[Disulone: focus on its indications in dermatology].
Topics: Dapsone; Granuloma; Humans; Lichen Planus; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Syst | 1990 |
Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency.
Topics: Administration, Oral; Adult; Complement C2; Dapsone; Female; Humans; Lupus Erythematosus, Cutaneous; | 1990 |
Bullous eruption in a patient with lupus erythematosus.
Topics: Adult; Dapsone; Female; Humans; Lupus Erythematosus, Cutaneous; Prednisone; Skin Diseases, Vesiculob | 1987 |